Skip to Content

93 7530 (Metformin Hydrochloride and Rosiglitazone Maleate 500 mg / 1 mg)

Pill with imprint 93 7530 is Yellow, Elliptical / Oval and has been identified as Metformin Hydrochloride and Rosiglitazone Maleate 500 mg / 1 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Metformin/rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/rosiglitazone 500 mg / 1 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7530

Metformin Hydrochloride and Rosiglitazone Maleate

Imprint:
93 7530
Strength:
500 mg / 1 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide